Avirmax Biopharma

Product Pipline

Avirmax Biopharma Inc. is at clinical stage of biotherapeutics development using rAAV delivery system. Currently, it is developing multiple rAAV candidates. The following are examples of Avirmax Biopharma’s product pipelines under development.

  • Indication
  • Lead Design & Production
  • AAV - Vector
  • Biochemical
  • Potency
  • Preclinical
  • IND - Enabling
  • Phase 1
  • Commercial Rights
  • Milestone

Wet AMD incl. PCV

ABI-110
0%

Enrolling

GA / dry AMD

ABI-201
0%

IND 2H25

PDR

ABI-202
0%

IND 2H26

Glaucoma

ABI-902
0%

IND 2H26

AMD: Age-related macular degeneration
GA: geographic atrophy
PCV: Polypoidal choroidal vasculopathy
PDR: Proliferative diabetic retinopathy